Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials
Chiang, N.-J.; Chen, L.-T.; Shan, Y.-S.; Yeh, C.-N.; Chen, M.-H. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules 2021, 11, 97. https://doi.org/10.3390/biom11010097
Chiang N-J, Chen L-T, Shan Y-S, Yeh C-N, Chen M-H. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules. 2021; 11(1):97. https://doi.org/10.3390/biom11010097
Chicago/Turabian StyleChiang, Nai-Jung; Chen, Li-Tzong; Shan, Yan-Shen; Yeh, Chun-Nan; Chen, Ming-Huang. 2021. "Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials" Biomolecules 11, no. 1: 97. https://doi.org/10.3390/biom11010097